Theraclion S.A.
OTC: TCLIF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Martin Deterre
- Employees
- 28
- Headquarters
- Malakoff, France
- IPO year
- 2019
- Market cap
- $25.1M
- Website
- https://www.theraclion.com
Loading TCLIF…
Loading profile data…Frequently asked questions about TCLIF
What does Theraclion S.A. (TCLIF) do?
Theraclion SA specializes in developing advanced echotherapy devices that harness high-intensity focused ultrasound technology. Its product portfolio includes SONOVEIN, a robotic, non-surgical echotherapy system specifically designed for treating varicose veins. Another key offering is ECHOPULSE, also a robotic and non-invasive echotherapy solut...
Where does TCLIF trade?
Theraclion S.A. (TCLIF) trades on the Other OTC.
What sector is TCLIF in?
Theraclion S.A. (TCLIF) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Theraclion S.A.?
Martin Deterre is the chief executive officer of Theraclion S.A. (TCLIF).
Where is Theraclion S.A. headquartered?
Theraclion S.A. is headquartered in France.
Does TCLIF pay a dividend?
Theraclion S.A. (TCLIF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TCLIF go public?
Theraclion S.A. (TCLIF) completed its initial public offering in 2019.